Prevalence of thyroid diseases in patients with acromegaly - Experience of a Brazilian center;Prevalência das doenças tireoidianas em pacientes com acromegalia - Experiência de um centro Brasileiro

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 57, Issue 9, 2013, Pages 685-690

  Uchoa, Helena Bandeira de Melo Paiva ^a   Lima, Giovanna Aparecida Balarini ^a,b   Corrêa, Lívia Lugarinho ^a   Vidal, Ana Paula Sieiro ^a   Cavallieri, Suzana Aquino ^c   Vaisman, Mário ^a   Buescu, Alexandru ^a   Gadelha, Mônica Roberto ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^c Labs D'Or Laboratório e Imagem   (Brazil)

Author keywords

Acromegaly; Cancer; Goiter; Thyroid

Indexed keywords

GROWTH HORMONE; IODIDE PEROXIDASE; SOMATOMEDIN C; THYROTROPIN;

ACROMEGALY; ADULT; AGED; ARTICLE; BLOOD; BRAZIL; CARCINOMA; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PREVALENCE; SEX RATIO; THYROID DISEASE; THYROID FUNCTION TEST; THYROID TUMOR; VERY ELDERLY;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; BRAZIL; CARCINOMA; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; IODIDE PEROXIDASE; MALE; MIDDLE AGED; PREVALENCE; SEX DISTRIBUTION; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID NEOPLASMS; THYROTROPIN;

EID: 84892425359     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302013000900003     Document Type: Article

References (35)

1. Melmed S. Acromegaly. N Engl J Med. 1990;322:966-977.
2. Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP. Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab. 2008;93:61-67.
3. Wright AD, Hill DM, Lowy C, Fraser TR. Mortality in acromegaly. Q J Med. 1970;39:1-16.
4. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol. 1980;12:71-79.
5. Nabarro JDN. Acromegaly. Clin Endocrinol. 1987;26:481-512.
6. Bengtsson B, Eden S, Ernest I, Oden A, Sjogren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand. 1988;223:327-335.
7. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol. 1994;41:95-102.
8. Orme SM, Mcnally RJQ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab. 1998;83:2730-2734.
9. Barzilari J, Heatley GJ, Cushing GW. Benign and Malignant tumors in patients with acromegaly. Arch Intern Med. 1991;151(8):1629-1632.
10. Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M; and the Pituitary Study Group. Increased incidence of neoplasia in patients with pituitary adenomas. Clin Endocrinol. 1998;49:441-445.
11. Jenkins PJ, Besser M. Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab. 2001;86(7):2935-2941.
12. Cheung NW, Boyages SC. The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol. 1997;46:545-549.
13. Kasagi K, Shimatsu A, Miyamoto S, Misaki T, Sakahara H, Konishi J. Goiter associated with acromegaly: sonographic findings of the thyroid gland. Thyroid. 1999;9:792-796.
14. Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, et al. High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol. 2005;63:161-167.
15. Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, et al. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multicenter study. J Endocrinol Invest. 2002;25:240-245.
16. Herrmann BL, Baumann H, Janssen OE, Görges R, Schmid KW, Mann K. Impact of disease activity on thyroid disease in patients with acromegaly: basal evaluation and follow up. Exp Clin Endocrinol Diabetes. 2004;112:225-230.
17. Balkany C, Cushing GW. An association between acromegaly and thyroid carcinoma. Thyroid. 1995;5:47-50.
18. Cannavò S, Squadrito S, Finocchiaro MD, Curtò L, Almoto B, Vieni A, et al. Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up. Horm Metab Res. 2000;32(5):190-195.
19. Kurimoto M, Fukuda I, Hizuka N, Takano K. The prevalence of benign and malignant tumors in patients with acromegaly in a single institute. Endocr J. 2008;55(1):67-71.
20. Miyakawa M, Saji M, Tsushima M, Wakai K, Shizume K. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels. J Clin Endocrinol Metab. 1988;67(5):973-978.
21. Derwahl M, Broecker M, Kraiem Z. Clinical review 101: thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab. 1999;84:829-834.
22. Ruchala M, Skiba A, Gurgul E, Uruski P, Wasko R, Sowinski J. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer. Neuro Endocrinol Lett. 2009;30(3):382-386.
23. Cheung NW, Boyages SC. Increased incidence of neoplasia in females with acromegaly. Clin Endocrinol. 1997;47(3):323-7.
24. Rogozinski A, Furioso A, Glikman P, Junco M, Laudi R, Reyes A, et al. Thyroid nodules in acromegaly. Arq Bras Endocrinol Metab. 2012;56(5):300-304.
25. Elmlinger MW, Kühnel W, Weber MM, Ranke MB. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP3). Clin Chem Lab Med. 2004;42:654-664.
26. Prando D. Anatomia ultrassonográfca normal da tireoide. In: Brandão LG. Tireóide e paratireóide: estudo de casos. São Paulo: Brandão LG; 2002. p. 311-316.
27. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159-1165.
28. Greene FL, Page D, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. (eds). AJCC Cancer Staging Manual, 6th ed. Springer-Verlag; 2002. p. 77-87.
29. Wüster C, Steger G, Schmelzle A, Gottswinter J, Minne HW, Ziegler R. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. Horm Metab Res. 1991;23(3):131-134.
30. Coeli MC, Brito AS, Barbosa FS, Ribeiro MG, Sieiro APAV, Vaisman M. Incidência e mortalidade por câncer de tireóide no Brasil. Arq Bras Endocrinol Metab. 2005;49(4):503-509.
31. Kauppinen-Mäkelin R, Sane T, Välimäki MJ, Markkanen H, Niskanen L, Ebeling T, et al. Increased cancer incidence in acromegaly - A nationwide survey. Clin Endocrinol (Oxf). 2009;72:277-279.
32. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, et al. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control. 2002;13:395-400.
33. Barzilari J, Heatley GJ, Cushing GW. Benign and malignant tumors in patients with acromegaly. Arch Intern Med. 1991;151(8):1629-1632.
34. Marchisotti FG, Umeda LM, Zach PL, Saldanha MD, First OS, Liberman B. [Acromegaly and thyroid disease: prevalence of thyroid cancer]. Arq Bras Endocrinol Metabol. 2005;49(5):843-849.
35. Dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH, Montenegro R, et al. Thyroid cancer in patients with acromegaly: a case control study. Pituitary. 2013;16(1):109-114.